Anti-Egfr×Anti-Fap Bi-Specific Targeting Antibody Combined with Irinotecan Encapsulated Liposomes for Pancreatic Cancer Therapy

Project: A - Government Institution › b - Ministry of Science and Technology

Project Details

StatusFinished
Effective start/end date8/1/18 → 7/1/19
View all
View less

Keywords

  • pancreatic cancer
  • liposomal drug
  • targeted liposome
  • bi-specific antibody

Access Project